Company Directory - Rapport Therapeutics, Inc.
Company Details - Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc.
WebsiteRapport Therapeutics, Inc. is a biotechnology company that develops therapeutics for various medical conditions.
CCI Score
CCI Score: Rapport Therapeutics, Inc.
-45.47
0.03%
Latest Event
Pharmaceutical Industry Political Contributions and Lobbying Efforts
An analysis of an OpenSecrets report reveals that the pharmaceutical and health products industry channels substantial political contributions and lobbying expenditures. This indicates an environment where financial influence may be used to push policies that uphold authoritarian norms. As a biotechnology company operating in this sector, Rapport Therapeutics, Inc. may be indirectly implicated in these practices.
Take Action
So what can you do? It's time to make tough choices. Where will you cast your vote?
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
QUISLING
Rapport Therapeutics, Inc. is currently rated as a Quisling.
Latest Events
- FEB062025
An analysis of an OpenSecrets report reveals that the pharmaceutical and health products industry channels substantial political contributions and lobbying expenditures. This indicates an environment where financial influence may be used to push policies that uphold authoritarian norms. As a biotechnology company operating in this sector, Rapport Therapeutics, Inc. may be indirectly implicated in these practices.
-50
Political Contributions and Lobbying Efforts
March 26
The OpenSecrets summary highlights extensive political contributions and lobbying activity by actors in the pharmaceutical and health products sector. While Rapport Therapeutics is not individually mentioned, its inclusion in this industry context raises concerns about potential complicity in channeling significant resources into political influence. Such practices can undermine democratic processes by favoring corporate power over public interest.
- MAR032020
The study exposes the vast sums spent by the pharmaceutical and health product industry on lobbying and campaign contributions, raising concerns about the potential undermining of democratic processes and the facilitation of policies that may favor authoritarian interests. For companies in this sector, such expenditures suggest a problematic alignment of corporate practices with political influence.
-70
Political Contributions and Lobbying Efforts
March 26
The article reveals that the pharmaceutical industry expended billions on lobbying and political contributions from 1999 to 2018. These activities are strategically aimed at influencing policy and election outcomes, which can erode democratic accountability and bolster authoritarian practices. As a biotechnology company operating within this industry, similar conduct by Rapport Therapeutics, Inc. would be seen as contributing to this problematic dynamic.
Alternatives
Thousand Oaks, USA
13.63
Cambridge, United States
0.27
Menlo Park, United States
-49.80
Corporation
0.00
Belgium (Ghent), Belgium
79.03
Raleigh, USA
56.52
Foster City, USA
1.64
China
0.00
_0.png?VersionId=E54j6B2ssY0mos4wxJcXCOh7Hall1IAR)
New York, United States
-1.65
Leverkusen, Germany
-8.11
Industries
- 325412
- Pharmaceutical Preparation Manufacturing
- 541715
- Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- 621511
- Medical Laboratories